Literature DB >> 2873522

Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain.

J Sawynok, A Reid.   

Abstract

The effect of baclofen and clonidine, both individually and in combination, on noradrenaline turnover was examined in several brain regions as well as in the spinal cord using the alpha-methyl-p-tyrosine depletion method. Baclofen (30-50 mg/kg) consistently increased the turnover of noradrenaline in the cortex, hippocampus and spinal cord and this effect was stereoselective for the L-isomer. Clonidine (0.1 mg/kg) decreased noradrenaline turnover in these regions and reversed the effect of baclofen. In the striatum, baclofen (50 mg/kg) decreased the turnover of dopamine in a stereoselective manner. Clonidine (0.1 mg/kg) did not alter dopamine turnover but potentiated the effect of baclofen. These results support behavioural data which suggests that baclofen interacts with central noradrenergic pathways. The nature of such interactions appears to be complex.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873522     DOI: 10.1007/bf00965340

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Alternative approaches to analgesia: baclofen as a model compound.

Authors:  D A Cutting; C C Jordan
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.

Authors:  P C Waldmeier; L Maître
Journal:  J Neurochem       Date:  1976-08       Impact factor: 5.372

3.  The analgesic action of baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid].

Authors:  R A Levy; H K Proudfit
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

4.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

5.  Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones.

Authors:  K Starke; H Montel
Journal:  Neuropharmacology       Date:  1973-11       Impact factor: 5.250

6.  Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, gamma-aminobutyric acid, gamma-hydroxybutyric acid, apomorphine and amphetamine.

Authors:  P H Kelly; K E Moore
Journal:  Neuropharmacology       Date:  1978-03       Impact factor: 5.250

7.  GABAB receptors and norepinephrine-stimulated cAMP production in rat brain cortex.

Authors:  E W Karbon; R S Duman; S J Enna
Journal:  Brain Res       Date:  1984-07-23       Impact factor: 3.252

8.  Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.

Authors:  G Gianutsos; K E Moore
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

9.  Effects of clonidine on the rate of noradrenaline turnover in discrete areas of the rat central nervous system.

Authors:  H P Lorez; D Kiss; M Da Prada; G Haeusler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

10.  Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.

Authors:  G Paalzow; L Paalzow
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more
  1 in total

1.  Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains.

Authors:  Laura H Jacobson; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2005-01-25       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.